Cb. Guzman et al., Altered myosin light-chain phosphorylation in resting platelets from premenopausal women with diabetes, METABOLISM, 50(2), 2001, pp. 151-156
Gender-related differences in the rate of coronary heart disease (CHD) betw
een premenopausal women and men are greatly diminished in women with diabet
es mellitus (DM). This may be related, in part, to altered platelet functio
n in premenopausal diabetic women. Hyperglycemia may contribute to increase
platelet aggregation through enhancement of oxidative stress, increased ni
tric oxide (NO) destruction, and increased myosin light-chain (MLC) phospho
rylation (MLC-P). Accordingly, we investigated functional acid biochemical
parameters of platelet function in 32 women (14 premenopausal and postmenop
ausal controls and 18 age-matched patients with DM); platelet MLC-P and cyc
lic guanosine monophosphate ([cGMP] reflecting NO) were assessed. Other par
ameters including age, body mass index (BMI), waist to hip ratio, total cho
lesterol, and platelet count were not different in the control and diabetic
groups. In the premenopausal women, baseline MLC-P was lower in women with
DM versus the control group (P = .02). GMP levels were similar in the two
groups at baseline (22.7 +/- 3 fmol/ml in controls v 23.1 +/- 3 fmol/ml in
diabetic subjects) and 3 minutes after insulin exposure. The platelet conte
nt of ascorbic acid (AA), an endogenous antioxidant compound, was elevated
in premenopausal women with DM (P = .02) compared with the controls. Despit
e similar estradiol (BE,) levels, platelets of premenopausal women with DM
exhibited reduced MLC-P. This paradoxic difference may be accounted for by
an increase in platelet AA, as this suggests decreased platelet oxidative s
tress in this patient population. These observations indicate that an alter
ed redox state and associated MLC-P of platelets does not contribute to enh
anced platelet aggregation and CHD in premenopausal women with DM. Copyrigh
t (C) 2001 by W.B. Saunders Company.